Clinical Trial Update: Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 pilot study of Ursodeoxycholic acid in non-alcoholic steatohepatitis has completed, evaluating serum ALT levels and serum markers for hepatic fibrosis a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Axcan Pharma | Conditions: Serum Levels of ALAT Transaminases, Serum Markers for Fibrosis and Hepatic Inflammation | Phase 2 | Status: COMPLETED